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AdultsAbstract Background: Human immune-deficiency virus/acquired immune-deficiency syndrome
predisposes to opportunistic parasitic infestations of the gastrointestinal tract. This study aimed
to determine the prevalence of intestinal parasites in newly diagnosed treatment naı¨ve HIV/AIDS
patients.
Methods: This hospital-based cross-sectional study was carried out from December 2010 to June
2011. Questionnaires were administered to 238 HIV/AIDS subjects, and 238 age and sex-
matched controls. CD4+ T cell count was carried out on HIV-positive subjects. Stool samples were
examined using direct microscopic and modified Ziehl-Neelsen methods. Positivity of intestinal par-
asites was taken as the presence of worms, oocyst, cyst, ova or larvae in the stool samples.
Results: Ninety males and 148 females were studied for the HIV-positive and HIV-negative con-
trols respectively. Intestinal parasitic infestation in HIV-positive subjects was 68.5%, and was sig-
nificantly higher than in the HIV-negative controls 49.2% (P< 0.05). In HIV-positive subjects,
Cryptosporidium spp. was the commonest (55.0%) parasite isolated. Others were Cyclospora cayeta-
nensis (41.2%), Isospora belli (3.0%), Entamoeba histolytica (8.4%), Giardia lamblia (3.7%), Ascaris
lumbricoides (2.5%), Strongyloides stercoralis (1.7%), Trichuris trichiura (0.8%) and Schistosoma
mansoni (0.4%). HIV-positive patients with CD4+ T cell count of less than 200 cells/ul were more
at risk of opportunistic parasites compared to the HIV-negative controls.
Conclusion: The prevalence of intestinal parasites in newly diagnosed HIV/AIDS individuals was
high, and its association with CD4+ T cell count was demonstrated. Routine screening for parasitic
infestations at diagnosis is indicated to reduce the burden of the disease.
 2016 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).(2016),
2 O.A. Obateru et al.1. Introduction
Human immune-deficiency virus/acquired immune-deficiency
syndrome (HIV/AIDS) is a global public health problem.1
The disease predisposes individuals to various opportunistic
infections of which parasitic infestations of the gastrointestinal
(GI) tract are prominent.2 Several studies have shown that
some intestinal parasites such as Cryptosporidium spp., Cyclos-
pora cayetanensis, Isospora belli, Entamoeba histolytica/dispar,
Strongyloides stercoralis, and Giardia lamblia are responsible
for 60–80% of infestations.3 Thus infestation of the GI tract
by these organisms plays a crucial role in HIV/AIDS patho-
genesis, and diarrhoea diseases assume a prominent role reach-
ing up to 50% in developing countries.2 The decrease in
immunity by attack on the immune system especially the clus-
ter of differentiation (CD4+ T cells) component, macro-
phages, and defect in the production of immunoglobulin A
(IgA) increases susceptibility to these parasites.4 Gut-
associated lymphatic tissue (GALT) in the GI tract is an
important site for early HIV replication and CD4+ T cell
replication.5
Helper T cells which are very important in adaptive immu-
nity, activate B cells to secrete antibodies, activate macro-
phages to destroy ingested microbes, and also activate
cytotoxic T cells to kill infected target cells. These functions
are impaired in patients with HIV/AIDS.6 Furthermore,
HIV/AIDS decrease the circulating pool of effector, and mem-
ory CD8+ T cells which combat viral infections. The end
result is immunosuppression.7 There have been reports of the
prevalence of intestinal parasites in HIV/AIDS patients in
other parts of Nigeria and the world.8–14 Ibrahim et al.8, and
Babatunde et al.9, in North central, Nigeria, found an increase
in the prevalence of intestinal parasites in HIV-positive
patients compared to HIV-negative controls. Similarly,
Akinbo et al.10, Hailemariam et al.11, Alemu et al.12, Jegede
et al.13, and Oyedeji et al.14 all found an increase in the preva-
lence and multiple intestinal parasitosis in HIV-positive Nige-
rian and Ethiopian patients compared with HIV-negative
controls. These studies were mostly on patients already on
highly active anti-retroviral therapy (HAART). There is a pau-
city of data on similar studies on treatment naı¨ve HIV/AIDS
patients. It is thus important to find out the common intestinal
parasites in newly diagnosed treatment naı¨ve adult HIV/AIDS
patients in Ilorin, Nigeria, since these parasites play a promi-
nent role in diarrhoeal diseases, and HIV/AIDS pathogenesis.
This study therefore aimed to determine the prevalence of
intestinal parasites in newly-diagnosed treatment naive
HIV/AIDS patients.
2. Subjects, materials and methods
The study was a hospital-based cross-sectional study carried
out over a six-month period (December 2010–June 2011), at
the Infectious disease clinic of University of Ilorin Teaching
Hospital (UITH), Ilorin, Nigeria. A standard structured ques-
tionnaire was administered to consecutive 238 newly diagnosed
treatment naive adult HIV/AIDS patients, and 238 age and
sex-matched HIV-negative controls whose blood and stool
samples were tested at first enrolment. Individuals who had
taken antibiotics, anthelmintic drugs and steroids prior to
enrolment were excluded from the study.Please cite this article in press as: Obateru OA et al. Prevalence of intestinal parasite
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Blood sample: Ten millilitres of venous blood samples were
collected aseptically into labelled EDTA specimen bottles.
Rapid Enzyme-linked immunosorbent assay (ELISA) was car-
ried out to detect antibodies to HIV 1 and 2 using rapid
ELISA test kit (AcuuBio Tech Co., Ltd., China). CD4+ T cell
count was carried out with Partec 4000 cyflow counter
Germany (2006) at the HIV laboratory of UITH.15 The range
of CD4+ T cell count was classified using the 1993 Center for
Disease Control and Prevention USA, immunological
criteria.16
Stool sample: Stool samples were collected into sterile con-
tainers, labelled, and analysed within 24 h of collection. Stool
samples were examined using direct microscopy for wet prepa-
ration, and iodine preparation.17,18 Modified Ziehl-Neelsen
methods, and Faecal concentration technique (using formol
ether concentration method) were also used to increase the
yield of intestinal parasites. Positivity of intestinal parasites
was taken as the presence of worms, ova, trophozoites, oocysts
and cysts in the stool samples.17–19
Data analysis: Epi-infoTM version 3.5.1(CDC, USA 2008)
software package was used for analysis. Statistical significance
was taken as p-value less than 0.05.
Ethical approval was obtained from the Ethics and
Research committee of UITH.
3. Results
There were 90 males (37.8%) and 148 females (62.2%) in both
groups, with a male to female ratio of 0.6:1. The age range for
both groups (HIV-positive subjects and HIV-negative controls)
was from 16 to 65 years. The mean age of respondents was 36.1
± 9.6 years and 35.9 ± 9.4 years for the HIV-positive subjects
and HIV-negative controls respectively. The commonest age
group was 26–35 years for both HIV-positive subjects and
HIV-negative controls. The mean age of the respondents was
similar (P> 0.05). Majority of the respondents were married,
and secondary school level of education was the highest level
of education attained by them. Most of the respondents were
of Yoruba ethnic origin, and trading was the major occupation
of the HIV-positive subjects, while most of the HIV-negative
controls were self-employed (Table 1).
The prevalence of intestinal parasites in HIV-positive
subjects and HIV-negative controls was 68.5% and 49.2%
respectively. HIV-positive subjects had increased risk of
intestinal parasites compared to HIV-negative controls
(P< 0.05); OR= 2.25 CI (1.52–3.32).
The most frequently detected parasites in the HIV-positive
subjects and HIV-negative controls were Cryptosporidium
spp. and C. cayetanensis. These were significantly higher in
the HIV-positive subjects than in HIV-negative controls
(55% vs 16.8%) (X2 = 73.97: P< 0.05) and (41.2% vs 8.4%)
(X2 = 66.81; P< 0.05) respectively. There were no statistically
significant differences in the prevalence of I. belli (3.0% vs
0.8%; X2 = 1.81: P> 0.05), E. histolytica (8.4% vs 8.8%)
(X2 = 1.0: P> 0.05), G. lamblia (3.7% vs 0%), Hookworm
spp. (0% vs 0.8%), S. stercoralis (1.7% vs 0.8%; P> 0.05),
Ascaris lumbricoides (2.5% vs 0%), Trichuris trichiura (0.8%
vs 0%), Schistosoma mansoni (0.4% vs 0%) in both groups
(Table 2).s in newly diagnosed HIV/AIDS patients in Ilorin, Nigeria, Alex J Med (2016),
Table 1 Socio-demographic characteristics of respondents.
HIV-positive subjects
frequency n (%)
HIV-negative
controls
frequency n (%)
Age (years)
16–25 42(17.6) 42(17.6)
26-35 89(37.4) 89(37.4)
36–45 68(28.6) 68(28.6)
46–55 33(13.9) 33(13.9)
56–65 6(2.5) 6(2.5)
Gender
Female 148(62.2) 148(62.2)
Male 90(37.8) 90(37.8)
Marital status
Single 59(24.8) 89(37.4)
Married 169(71.0) 148(62.2)
Divorced 7(2.9) 1(0.4)
Widowed 3(1.3) 0(0)
Ethnicity
Hausa 10(4.2) 12(5.0)
Yoruba 171(71.9) 191(80.3)
Ibo 12(5.0) 9(3.8)
Others 45(18.9) 26(10.9)
Level of education
No formal education 65(27.3) 27(11.3)
Primary 70(29.4) 52(21.8)
Secondary 75(31.5) 83(34.9)
Tertiary 19(8.0) 68(28.6)
Quranic 9(3.8) 8(3.4)
Occupation
Unemployed 37(15.6) 30(12.6)
Self employed 67(28.1) 61(25.6)
Students 7(2.5) 45(18.9)
Traders 77(32.4) 37(15.6)
Civil servants 42(17.6) 44(18.5)
Professionals 9(3.8) 21(8.8)
Prevalence of intestinal parasites 3Some respondents were infected with up to four different
parasites. HIV-positive subjects had more multiple parasitic
infestation rates (more than one) than the HIV-negative con-
trols 33.2% (79/238) and 25.6% (61/238) respectively
(X2 = 34.13; P< 0.05) (Fig. 1).Table 2 Distribution of intestinal parasitic species in respondents.
Parasites HIV-positive HIV-negati
(1) Cryptosporidium spp. 131(55.0) 40(16.8)
(2) Cyclospora spp. 98(41.2) 20(8.4)
(3) Isospora belli 7(3.0) 2(0.8)
(4) E. histolytica 20(8.4) 21(8.8)
(5) Giardia lamblia 9 (3.7) 0(0)
(6) Hookworm spp. 0(0) 2(0.8)
(7) S. Stercoralis 4(1.7) 2(0.8)
(8) A. lumbricoides 6(2.5) 0(0)
(9) Trichuris trichiura 2(0.8) 0(0)
(10) S. mansoni 1(0.4) 0(0)
S-significant.
NS-not significant.
* p value from Fishers exact test.
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was 13–883 cells/ul. The mean CD4+ T cell count was 257
± 201.7. HIV-positive patients with CD4+ T cell count
<200 cells/ul had increased risk of intestinal parasitic infesta-
tion (p= 0.017; OR 1.95: CI = I.09–3.55) compared to those
with CD4+ T cell count of 200–499 (p= 0.760; OR = 1.09,
CI = 0.59–2.04) and those with CD4+ T cell count >500
(p= 1.00; OR = 0.24, CI = 0.10–0.54) (Table 3).
4. Discussion
Intestinal parasites, especially the opportunistic ones are a
common cause of morbidity and mortality in HIV/AIDS
patients.8 The prevalence of intestinal parasites in HIV-
positive subjects in this study was found to be high (68.5%).
Studies carried out in other parts of Nigeria showed diversity
in findings. The figure of 68.5% is lower than the 87.8%
reported in an earlier study carried out in our centre by Baba-
tunde et al.9 Ibrahim et al. in North-central Nigeria, docu-
mented a figure of (50.0%).8 Akinbo et al. in South-south
Nigeria reported 15.3%.10 This variation in prevalence is not
different from that documented in Africa and other parts of
the world. Hailemariam et al.11 and Alemu et al.12 in Ethiopia
reported a prevalence of 52.6% and 80.3% respectively.
Kipyegen et al. in Kenya documented a parasitic prevalence
in HIV-positive patients which is to be 50.0%).20
Da silva et al. in Brazil found a prevalence rate of 27.0%.21
Mohandas et al. in India found out that 30.0% of HIV-
positive patients harbour intestinal parasites.22
HIV-positive subjects in this study were all newly diagnosed
and treatment naı¨ve in contrast to the other studies mentioned
above. Furthermore, the study subjects in aforementioned
studies, were a combination of those on treatment and treat-
ment naı¨ve. They may have used anthelmintic drugs such as
Albendazole, Piperazine, Levamisole, and HAART. This
may have boosted their immunity and subsequently altered
the intestinal flora in the gut.14 Sampling techniques and obser-
ver differences in the examination of stool samples may be
another factor responsible for these differences in prevalence
even though most of the studies involved the use of direct
wet mount, formalin-ether sedimentation concentration, and
modified Ziehl Neelsen methods. However, Hailemariam
et al.11 did not use Ziehl Neelsen method.ve Chi-squared p-value Comment
73.97 <0.05 S
66.81 <0.05 S
1.81 >0.05* NS
1.0 >0.05 NS
– – –
– – –
– >0.05* –
– – –
– – –
– – –
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Figure 1 Multiple parasitic infestation rate in respondents.
Table 3 Distribution of intestinal parasites in HIV-positive subjects at different values of CD4+ T cell count (cells/ul).
CD4+ T n (%) Intestinal parasites n (%) Odds ratio (95% CI) p-value
Cell count n= 238 n= 163
<200 125(52.5) 94(57.7) 1.95(1.09–3.55) 0.017
200–499 79(33.2) 55(33.7) 1.09(0.59–2.04) 0.760
>500 34(14.3) 14(8.6) 0.24(0.10–0.54) 1.000
4 O.A. Obateru et al.Cryptosporidium spp. was found to be the most predomi-
nant intestinal parasite in HIV-positive subjects (55.0%). Stud-
ies carried out in Ile-Ife, South-west Nigeria, by Oyedeji et al.14
and Adesiji et al.23 found the most predominant intestinal par-
asite in HIV-positive subjects to be Cryptosporidium spp.
(19.2% and 52.7%), and Thomas et al. in Lagos, South-west
Nigeria, documented similar findings.24 However, this is in
contrast to the findings by Nwokediuko et al. in Enugu,
South-east Nigeria25 and Oyerinde et al. in Lagos26, who
reported a rarity of Cryptosporidium spp. This is unusual, as
Cryptosporidium spp. infection has been documented even in
apparently normal individuals by Ikeh et al.27, Nwabuisi28,
and Banwat et al.29 all in North-central Nigeria. The prevailing
environmental conditions may not be favourable for the trans-
mission of these parasites in that part of the country, which
may have accounted for the reported low incidence of Cryp-
tosporidium spp. in those regions. These studies were noted
to have been carried out on patients with diarrhoea; hence,
they may have taken anthelmintic drugs such as Albendazole,
Piperazine, and Levamisole prior to enrolment into the studies.
The findings of Oyedeji et al.14 were influenced by the prior use
of ant-helminthics and Co-trimoxazole. Jegede et al.13 in
North central, Nigeria, did not find any statistical difference
in the spectrum of intestinal parasites between HIV-positive
and HIV-negative controls.
However, studies in Nigeria by Wokem et al.30 and Ethio-
pia by Hailemariam et al.11 found A. lumbricoides to be the
most predominant parasites in HIV-positive subjects. S. ster-
coralis was found to be most predominant in HIV-positive
subjects in Thailand.31 Further studies need to be carried out
in those geographical areas to validate these findings as oppor-
tunistic parasites are expected to thrive more in HIV-positive
patients.
From this study, C. cayetanensis was detected in a
significant number of HIV-positive subjects compared toPlease cite this article in press as: Obateru OA et al. Prevalence of intestinal parasite
http://dx.doi.org/10.1016/j.ajme.2016.04.001HIV-negative controls (41.2% vs 8.4%). This differs from
reports in some parts of Nigeria and the world at large, in
which the prevalence was found to be low or unde-
tected.23,24,32,33 The geographical variation and the remarkable
similarity in morphologic features with Cryptosporidium spp.
could account for these differences. The presence of Cryp-
tosporidium spp. and C. cayetanensis in the HIV-negative con-
trols may be due to the fact that asymptomatic carrier state can
occur in immune-competent individuals and they only become
symptomatic with diarrhoeal disease, when they become
immune-deficient.28,30,34,35 Reports by Nwabuisi28 in Ilorin,
and Banwat et al.29 in Jos, North-central Nigeria, have shown
that infection with Cryptosporidium spp. and C. cayetanensis
can occur in immuno-competent individuals. Poor personal,
and environmental hygiene which could facilitate transmission
of the cyst and ova of parasites may be responsible in this part
of the world.
The rate of multiple parasitic infestations was 33.2% and
25.6% in HIV-positive and HIV-negative controls respectively.
A report from Jos by Ibrahim et al.8, found multiple parasitic
infection rates in HIV-positive subjects to be lower (13%),
while Hailemariam et al.11, and Alemu et al. documented a
high multiple parasitic infestation rate of 91.3%.12 This may
be attributed to depressed immunity in the HIV-positive sub-
jects, which predisposed them to mixed infections including
the opportunistic and non-opportunistic parasites.
HIV-positive patients withCD4+T cell count < 200 cells/ul
had increased risk of intestinal parasitic infestation (P< 0.05)
compared to those with CD4+ T cell count of >200. Majority
of HIV-positive subjects with CD4+ T cell count of
<200 cells/ul hadmore than double the risk of developing diar-
rhoea (P< 0.05) compared to those with CD4+ T cell count of
>200. This is in keeping of reports from earlier studies carried
out by Babatunde et al.9, Wiwanitkit31 and Assefa et al.32 All
these findings have shown that immunity plays a major role ins in newly diagnosed HIV/AIDS patients in Ilorin, Nigeria, Alex J Med (2016),
Prevalence of intestinal parasites 5the survival and proliferation of intestinal parasites in HIV-
positive patients.
A major limitation in this study, is the fact that other stain-
ing techniques such as modified trichome staining technique
were not used which could have detected Microsporidia
spores.
In conclusion, the prevalence of intestinal parasites in treat-
ment naive adult HIV/AIDS individuals was found to be high.
HIV-positive individuals with CD4+ T cell count less than
200 cells/ul were more at risk of infestations with intestinal
parasites, and multiple intestinal parasites than those with
more than 200 cell/ul. Apparently normal individuals also har-
bour opportunistic parasites.
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